311 related articles for article (PubMed ID: 8865549)
1. Factor VIII inhibitor and severity of hemophilia.
Schoppmann A; Waytes AT
Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
[No Abstract] [Full Text] [Related]
2. Recombinant factor VIII in hemophilia.
Cohen A; Butler R
N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
[No Abstract] [Full Text] [Related]
3. World registry on factor VIII inhibitor patients: why?
Aledort LM
Semin Hematol; 1993 Apr; 30(2 Suppl 1):7-9. PubMed ID: 8480198
[No Abstract] [Full Text] [Related]
4. Previously untreated patients and recombinant factor VIII concentrate studies.
Pasi KJ
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S29-32. PubMed ID: 9351534
[TBL] [Abstract][Full Text] [Related]
5. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Brackmann HH; Gormsen J
Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
[No Abstract] [Full Text] [Related]
6. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
Monahan PE; Aledort LM;
Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
[TBL] [Abstract][Full Text] [Related]
7. Experiences with recombinant factor VIII products: development of inhibitors and immune tolerance therapy.
Scharrer I; Neutzling O; Schwaab R; Oldenburg J; Ehrlich H
Ann Hematol; 1998; 76 Suppl 1():A1-6. PubMed ID: 9542469
[No Abstract] [Full Text] [Related]
8. Rapid elimination of a high-titered F VIII inhibitor by high dose recombinant F VIII combined with high dose immunoglobulin infusion.
Mauz-Korholz C; Korholz D; Gobel U
Thromb Haemost; 1997 Aug; 78(2):959. PubMed ID: 9268203
[No Abstract] [Full Text] [Related]
9. A case report of a premature infant with haemophilia A and factor VIII inhibitor.
Cartledge P; Deakin K; McKecknie L; Richards M
Haemophilia; 2011 Jul; 17(4):711-2. PubMed ID: 21371187
[No Abstract] [Full Text] [Related]
10. Surgery in haemophilic patients with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
[No Abstract] [Full Text] [Related]
11. Recombinant factor VIII in hemophilia A: the Canadian experience.
Blanchette VS
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
[TBL] [Abstract][Full Text] [Related]
12. New treatment for hemophilia.
FDA Consum; 2003; 37(6):5. PubMed ID: 14983810
[No Abstract] [Full Text] [Related]
13. Cumulative analysis of inhibitor formation in patients with haemophilia A treated with sucrose-formulated recombinant factor VIII.
Bajwa N; Enriquez MM; Gorina E; Lemm G
Haemophilia; 2009 Mar; 15(2):597-600. PubMed ID: 19187195
[No Abstract] [Full Text] [Related]
14. Recombinant antihemophilic factor.
Med Lett Drugs Ther; 1993 Jun; 35(898):51-2. PubMed ID: 8497206
[No Abstract] [Full Text] [Related]
15. Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.
Bray G
Ann Hematol; 1994; 68 Suppl 3():S29-34. PubMed ID: 8180254
[No Abstract] [Full Text] [Related]
16. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
17. Factor VIII inhibitors.
Gilles JG; Jacquemin MG; Saint-Remy JM
Thromb Haemost; 1997 Jul; 78(1):641-6. PubMed ID: 9198231
[No Abstract] [Full Text] [Related]
18. [Recombinant factor VIII].
Tusell JM
Sangre (Barc); 1993 Apr; 38(2):139-42. PubMed ID: 8516727
[No Abstract] [Full Text] [Related]
19. Development and introduction of recombinant factor VIII--a clinician's experience.
Lusher JM
Haemophilia; 2012 Jul; 18(4):483-6. PubMed ID: 22512315
[No Abstract] [Full Text] [Related]
20. The challenges of inhibitor patient care.
Goldsmith JC
Semin Hematol; 1993 Apr; 30(2 Suppl 1):1-2. PubMed ID: 8480191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
